Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

Britain's GSK and drug developer iTeos Therapeutics said on Tuesday they have stopped developing an experimental lung cancer ...

Both nations pledged to cut their broad, ballooning tariffs after weekend talks. US tariffs dropped to 30% from 145%, while ...

We’re winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true.

A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to researchers. In a trial where cancers were treated with chemotherapy ...

Roche’s Herceptin and Perjeta duo is already part of a well-established standard of care in early-stage HER2-positive breast ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

Treating patients with a drug before surgery greatly reduced the chances of the cancer coming back, a small trial found.

LISTEN: Price caps lead to shortages. Want to reduce costs? Allow drug companies to sell directly and eliminate the middlemen ...